A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

PHASE3CompletedINTERVENTIONAL
Enrollment

509

Participants

Timeline

Start Date

September 14, 2015

Primary Completion Date

December 5, 2018

Study Completion Date

June 27, 2024

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Olaratumab

Administered IV

DRUG

Doxorubicin

Administered IV

DRUG

Placebo

Administered IV

Trial Locations (114)

333

Chang Gung Memorial Hospital - Linkou, Taoyuan Hsien

1062

Magyar Honvedseg Egeszsegugyi Kozpont, Budapest

1090

AKH, Vienna

1200

Cliniques universitaires Saint-Luc, Brussels

1426

Alexander Fleming, CABA

2050

Chris O'Brien Lifehouse, Camperdown

2730

Herlev and Gentofte Hospital, Herlev

3000

Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven

3010

Inselspital Bern, Bern

9000

Universitair Ziekenhuis Gent, Ghent

9007

Cantonal Hospital St.Gallen, Sankt Gallen

10002

National Taiwan University Hospital, Taipei

10032

Columbia University Medical Center, New York

10060

Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo

10065

Memorial Sloan Kettering Cancer Center, New York

10408

National Cancer Center, Goyang-si

11217

Taipei Veterans General Hospital, Taipei

13125

HELIOS Klinikum Berlin-Buch, Berlin

13385

CHU Hopital d'enfants de la Timone, Marseille

15232

University of Pittsburgh Medical Center, Pittsburgh

19106

Pennsylvania Oncology Hematology Associates, Philadelphia

20089

Istituto Clinico Humanitas, Rozzano

20133

Istituto Nazionale dei Tumori, Milan

21079

Centre Georges François Leclerc, Dijon

22010

Hospital Angeles, Tijuana

22031

Fairfax Northern Virginia Hematology Oncology, PC, Fairfax

22185

Skånes universitetssjukhus Lund, Lund

27710

Duke Cancer Institute, Durham

28040

Hospital Clinico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

30341

Georgia Cancer Specialists PC, Atlanta

31059

Institut Claudius Regaud, Toulouse

32224

Mayo Clinic in Florida, Jacksonville

33076

Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux

33521

Tampereen yliopistollinen sairaala, Tampere

33612

Moffitt Cancer Center & Research Institute, Tampa

37203

Oncology Hematology Care Inc, Nashville

Tennessee Oncology PLLC, Nashville

38138

The West Clinic, Germantown

41013

Hospital Universitario Virgen Del Rocio, Seville

44280

Hospital Civil Fray Antonio Alcalde, Guadalajara

45014

Oncology Hematology Care Inc, Fairfield

45122

Universitaetsklinikum Essen, Essen

45202

Oncology Hematology Care Inc, Cincinnati

45211

Oncology Hematology Care Inc, Cincinnati

45230

Oncology Hematology Care Inc, Cincinnati

45236

Oncology Hematology Care Inc, Cincinnati

46026

Hospital Universitario La Fe de Valencia, Valencia

48109

University of Michigan, Ann Arbor

63110

Washington University Medical School, St Louis

64320

Consultorio Dr. Reinoso, Monterrey

68114

Nebraska Methodist Cancer Center, Omaha

68167

Klinikum Mannheim gGmbH Universitätsmedizin, Mannheim

69008

Centre Leon Berard, Lyon

72076

Universitätsklinikum Tübingen, Tübingen

75248

Institut Curie, Paris

78213

Centro de Alta Especialidad Reumatologia Inv del Potosi SC, San Luis Potosí City

80045

University of Colorado Cancer Center, Aurora

81377

Klinikum der Universität München Großhadern, München

84106

Utah Cancer Specialists, Salt Lake City

84112

University of Utah School of Medicine, Salt Lake City

87102

University of New Mexico Cancer Center, Albuquerque

90024

UCLA Medical Center, Los Angeles

94305

Stanford University, Stanford

94805

Gustave Roussy, Villejuif

95123

Università degli Studi di Catania - Azienda Policlinico, Catania

97134

Centro de Atención E Investigación Clínica En Oncología, Mérida

97239

Oregon Health and Science University, Portland

115478

Blokhin Cancer Research Center, Moscow

197758

St-Petersburg scientifical practical cente spec medical care, Saint Petersburg

420029

Kazan Oncology Dispensary, Kazan'

5265601

Sheba Medical Center, Tel Litwinsky

6423906

Tel Aviv Sourasky Medical Center, Tel Aviv

9112001

Hadassah Medical Center, Jerusalem

91010-0269

City of Hope National Medical Center, Duarte

02215

Dana Farber Cancer Institute, Boston

37232-6307

Vanderbilt University Medical Center, Nashville

C1125ABD

CENIT Centro de Neurociencias, Investigación y Tratamiento, Caba

S2002KDS

Hospital Provincial del Centenario, Rosario

20220-410

INCA Hospital do Câncer III, Rio de Janeiro

01246-000

Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo

T2N4N2

Tom Baker Cancer Center, Calgary

V5Z 4E6

BC Cancer Vancouver, Vancouver

Unknown

Princess Margaret Hospital (Ontario), Lai Chi Kok

H4A 3J1

Royal Victoria Hospital-Montreal, Montreal

SF-20520

Turku University Central Hospital, Turku

466-8560

Nagoya University Hospital, Nagoya

277-8577

National Cancer Center Hospital East, Kashiwa

003-0804

National Hospital Organization Hokkaido Cancer Center, Sapporo

565-0871

Osaka University Hospital, Suita

350-1298

Saitama Medical University International Medical Center, Hidaka

104-0045

National Cancer Center Hospital, Chuo-Ku

135-8550

Japanese Foundation for Cancer Research, Koto-ku

811-1395

National Hospital Organization Kyushu Cancer Center, Fukuoka

700-8558

Okayama University Hospital, Okayama

540-0006

National Hospital Organization Osaka National Hospital, Osaka

541-8567

Osaka International Cancer Institute, Osaka

6229 HX

Maastricht UMC+, Maastricht

9713 GZ

University Medical Center Groningen, Groningen

2333 ZA

Leids Universitair Medisch Centrum, Leiden

6525 GA

Universitair Medisch Centrum St Radboud Nijmegen, Nijmegen

3015 GD

Erasmus Medisch Centrum, Rotterdam

02-781

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Warsaw

05505

Asan Medical Center, Seoul

06591

Seoul St. Mary's Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

06351

Samsung Medical Center, Seoul

08035

Hospital Universitari Vall d'Hebron, Barcelona

08907

Hospital Duran I Reynals, Barcelona

NW1 2BU

University College Hospital - London, London

SW3 6JJ

Royal Marsden NHS Trust, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

CH63 4JY

The Clatterbridge Cancer Centre, Bebbington

S10 2SJ

Weston Park Hospital, Sheffield

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02451943 - A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter